newsfilter
← Latest News
GlobeNewswire·

MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

Initial MGC026 (B7-H3 ADC) Phase 1 results in mid-2026Initial MGC028 (ADAM9 ADC) Phase 1 results in second half of 2026Lorigerlimab Phase 2 LINNET study update in mid-2026IND submission for MGC030, a first-in-class